Post Marketing Data: Adverse drug reactions (ADRs) identified during Post-marketing experience with hexetidine are included. The frequencies are provided according to the following convention: Very common ≥1/10; Common ≥1/100 and <1/10; Uncommon ≥1/1,000 and <1/100; Rare ≥1/10,000 and <1/1,000; Very rare <1/10,000; Not known (cannot be estimated from the available data).
In the table as follows, ADRs identified are presented by frequency category based on incidence in adequately designed clinical trials or epidemiology studies, if available or when incidence is unavailable, frequency category is listed as Not known. (See table.)
Click on icon to see table/diagram/image